Article
Exploring the Therapeutic Potential of Camalexin in Benomyl- induced Parkinson’s Disease in Mice: In vitro, In vivo and Aldehyde Dehydrogenase Insights
2024-08-21
Abstract excerpt
<title>Abstract</title> <p>Camalexin was selected in this study due to its ALDH-enhancing gene and its aldehyde dehydrogenase and dopamine protective roles have been evaluated. Also, the role of Benomyl in affecting the aldehyde dehydrogenase enzyme (both ALDH1A1 and ALDH2) was countered with the effect of pesticides on the neurological system of humans. The work aims to provide a suitable multi-targeted molecule...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Genetic Neurodegenerative Diseases
- Neurological and metabolic disorders
- Neuroscience and Neuropharmacology Research
- Olfactory and Sensory Function Studies
- Parkinson's Disease Mechanisms and Treatments
- Plant biochemistry and biosynthesis
- RNA regulation and disease
Identifiers and source
- Literature Corpus work
- 280ed493-b244-56b8-a954-9efbe6adfc56
- DOI
- 10.21203/rs.3.rs-4799031/v1
